Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia.

Bone Marrow Transplant · 2022 · PMC9392432 · PMID 35987913

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although this finding did not reach statistical significance due to small sample size, patients undergoing alloSCT had a high rate of non-relapse mortality (1-year NRM 44.8%) despite low HCT-CI of 0–2 in most patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.